News | January 20, 2015

University of Tennessee Engineering Research Offers Hope for Heart Valve Patients

Teams working to create calcification-proof tissue-engineered heart valves

Tennessee, Knoxville, heart valve, tissue engineered, calcification proof

January 20, 2015 — There could soon be new hope for those facing one of humanity's biggest health issues, thanks to research from the University of Tennessee Knoxville College of Engineering. 

Cardiovascular diseases are the world's number one cause of death, with some estimates indicating that as many as one-third of the planet's deaths in a given year are attributable to some form of the disease. 

While heart valve disease is only one of many afflictions falling under that heading, its widespread impact — affecting up to 30 percent of the elderly population in developed countries alone — makes it a key component of the overall problem of heart-related ailments.

Zannatul Ferdous, an assistant professor in UT's Department of Mechanical, Aerospace, and Biomedical Engineering, leads a research team addressing the issue, thanks in part to a BRIGE — Broadening Participation Research Initiation Grants in Engineering — grant from the National Science Foundation.

"Currently, the treatment option for valve disease is mainly end-stage replacement or repair surgeries, and no early treatment or detection options exist," said Ferdous. "The goal of our lab is to understand these diseases and develop alternate treatment options such as functional tissue-engineered heart valves."

One of the main issues with heart valves that the group is focusing on is what is known as calcification, a process where calcium deposits build up on the valves, eventually restricting the flow of blood through the heart. 

By studying the root causes of calcification and constructing new heart valves through tissue engineering — using cells to construct organic human tissue — Ferdous and her group aim to eventually develop calcification-proof valves. 

“We are tackling calcification head-on, looking at risk factors from everything like age and gender to chemical factors and cell characteristics," said Ferdous. "At the same time, we are developing custom devices that will allow us to truly mimic all the forces at play in the heart.”

For more information: www.mabe.utk.edu

Related Content

Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
The ChordArt transcatheter mitral valve leaflet chord replacement system on X-ray, showing the anchoring sections of the artificial chord.

The ChordArt transcatheter mitral valve leaflet chord replacement system on X-ray, showing the anchoring sections of the artificial chord.

News | Heart Valve Technology| August 01, 2017
Aug.
Hitachi and West Virginia University Partner to Advance Left Ventricular Mechanical Function Evaluation
News | Cardiovascular Ultrasound| July 21, 2017
Hitachi Healthcare and the West Virginia University Heart and Vascular Institute announced the formation of a new...
Edwards Sapien 3 TAVR valve will be implanted in asymptomatic aortic stenosis patients in the EARLY TAVR Trial
Feature | Heart Valve Technology| July 14, 2017
July 14, 2017 — Morristown Medical Center, part of Atlantic Health System, has randomized the first patient in the wo
Ziosoft's PhyZiodynamics 4-D processing showing a replaced aortic valve

An example of Ziosoft's PhyZiodynamics 4-D processing showing a replaced aortic valve.

Technology | Computed Tomography (CT)| July 12, 2017
July 12, 2017 — At the 2017 annual meeting for the Society of Cardiovascular Computed Tomography (SCCT), Ziosoft show
Medtronic's CoreValve Evolut R gained FDA approval for intermediate risk patients

An illustration of the self-expanding CoreValve Evolut R TAVR valve half deployed in the aortic root.

Feature | Heart Valve Technology| July 10, 2017
The U.S. Food and Drug Administration (FDA) has cleared an additional indication to expand the use Medtronic's self-...
HAART 300 Aortic Annuloplasty Device Sees U.S. Pilot Launch, First Commercial Use
News | Annuloplasty Rings| July 05, 2017
July 5, 2017 — BioStable Science & Engineering Inc.
Novel Approach May Improve Valve Function in Some Patients

Image courtesy of Messas, et al. JACC Basic to Translational Medicine.

News | Heart Valve Technology| June 30, 2017
June 30, 2017 — Pulsed cavitation ultrasound can be used to remotely soften human degenerative calcified biosprosthet
Overlay Init